3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Neoplasms
3
Breast Neoplasms
2
Solid Tumours
1
Side-effect of Antibiotic
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Long QT Syndrome
1
Hot Flashes
1
Hodgkin Disease
1
Carcinoma, Renal Cell
1
Bacteremia
1
Advanced Breast Cancer
1
Interventions
telavancin
1
Moxifloxacin
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bacteremia
×
Moxifloxacin
×
Clear all
NCT00398411
2015-06-29
MoxiProph
University of Cologne
Phase 3
Completed
66 enrolled
15 charts